ReviewFrontiers in physiology2026
AI-enhanced non-invasive monitoring of critical biochemical analytes in perioperative care: a review of signal processing and clinical applications.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current perioperative monitoring of critical biochemical analytes predominantly relies on intermittent arterial blood gas analysis, which carries inherent risks of invasiveness and discontinuous data acquisition. Emerging evidence suggests that variations in electrocardiogram and photoplethysmogram waveforms may hold significant predictive value for detecting critical biochemical analytes changes. Advances in artificial intelligence analysis technologies have further accelerated the development of non-invasive monitoring tools, including real-time non-invasive blood glucose monitoring for diabetic patients and blood potassium monitoring for renal dialysis patients. This review highlights the urgent clinical need for non-invasive, continuous monitoring of the critical biochemical analytes during the perioperative period. It provides a comprehensive summary of current monitoring technologies and signals related to critical biochemical analytes, with a focus on their potential application in non-invasive blood gas monitoring. Based on existing evidence, key analytes such as serum potassium, serum calcium, lactate, and blood glucose have demonstrated robust research foundations and are the primary focus of this review. However, further clinical validation is urgently required to confirm their reliability and applicability in clinical settings. Integrating artificial intelligence with traditional monitoring systems has the potential to significantly enhance the precision, timeliness, and effectiveness of perioperative care. These findings suggest that AI-enhanced non-invasive monitoring could reduce unnecessary blood sampling while providing earlier detection of critical biochemical analytes disorder. Successful clinical translation requires standardized validation protocols and hardware-software co-development to address current limitations in measurement consistency and clinical workflow integration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.